- Front Page
- Registrant group for Cetrimonium Bromide (CTAB)
- Registrant group for Reaction mass of C12 trimethylammonium bromide and C14 trimethylammonium bromide
- Registrant group for Tetradonium Bromide
- Why us
- Download & Publications
- Contact us
BioProcess International European Summit
BioProcess International European Summit gives you access to innovative science and technology across the entire bioprocessing spectrum. Accelerate your biologics, mAbs, vaccines and novel products towards commercial success.
Increase specific Influenza production with recombinant human insulin
The vaccine industry is challenged to produce large quantities of vaccines in a rapid and cost-effective way. Major changes to current bioprocesses are both difficult and very
expensive to implement. It has been demonstrated using HEK293 cells that addition of animal origin free human insulin to commercially available off-the-shelf chemically defined
media, can be used as a supplement to increase VCD, productivity and specific viral yield.